Brightsurf Science News & Current Events

December 28, 2005
First analysis of FDA's mifepristone adverse event reports
The abortion drug mifepristone (Mifeprex,TM RU-486), initially touted as a more convenient alternative to surgical abortion, has been linked to serious adverse reactions, including several deaths in otherwise healthy women.

Study suggests way to re-energize immune response to chronic viral infection
Like boxers wearied by a 15-round bout, CD8 T cells eventually become

Penn study finds hyperbaric oxygen treatments mobilize stem cells
According to a study to be published in the American Journal of Physiology-Heart and Circulation Physiology, a typical course of hyperbaric oxygen treatments increases by eight-fold the number of stem cells circulating in a patient's body.

University of Colorado student-built instrument set to launch on Pluto mission
The University of Colorado at Boulder's long heritage with NASA planetary missions will continue Jan.

Pediatric oncologists should help with difficult decisions
The oncologist should be the primary decision maker in some pediatric cancer situations, say researchers at Baylor College of Medicine (BCM) in Houston in an article appearing today in the Journal of Clinical Oncology.

Bipolar disorder more common than expected in hospitalized adolescents
Clinicians at Bradley Hospital, the nation's first psychiatric hospital for children and adolescents, have found that bipolar disorder is more common than expected in teens in a psychiatric inpatient setting.

Medicare drug benefit could do harm to poor, elderly, and disabled
A perspective article by Stephen Soumerai, professor in the Department of Ambulatory Care and Prevention (of Harvard Medical School and Harvard Pilgrim Health Care), suggests that the new Medicare Drug Benefit may be harmful to the health of the poor, elderly, and disabled, the so-called

Scientists lift malaria's cloak of invisibility
The world's deadliest malaria parasite, Plasmodium falciparum, sneaks past the human immune system with the help of a wardrobe of invisibility cloaks.

Positive outcome of Medicare drug benefit
An editorial by Richard Platt, professor and chair of the Department of Ambulatory Care and Prevention (of Harvard Medical School and Harvard Pilgrim Health Care), says that an unintended effect of the Medicare Drug Benefit could be the creation of the world's most valuable resource for understanding how drugs are used, as well as their risks and benefits, especially among the elderly and chronically ill.

Sleep researchers from five European countries will study the mechanism of sleep regulation
Dr. Tarja Porkka-Heiskanen (Stenberg) MD, PhD, at the Institute of Biomedicine, University of Helsinki, coordinates a new EU-funded project, which addresses the mechanisms of sleep regulation.

Researchers discover how a high-fat diet causes type 2 diabetes
Howard Hughes Medical Institute researchers have discovered a molecular link between a high-fat, Western-style diet, and the onset of type 2 diabetes.

Conflict resolution in cyberspace
Thanks to support from successive EU-funded projects, Tiga Technologies, an advanced IT consultancy, is creating a spin-off company to commercialise a pioneering electronic arbitration system called e-DisputeĀ©.

FDA grants REVLIMIDĀ® NDA approval
Celgene Corporation (NASDAQ: CELG) announced that the US Food and Drug Administration (FDA) granted approval of REVLIMID (lenalidomide) which is indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.

UCSD team discovers diabetes trigger in fatty diet
A new study, published in the December 29 issue of the journal Cell, reports the discovery of a molecular link between a high-fat, or Western-style, diet, and the disruption of insulin production, explaining how a high-fat diet causes type 2 diabetes.

High demand for structured doctoral programmes
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved 26 new Research Training Groups. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to